Patent Granted for the 𝙉𝙚𝙪𝙧𝙤𝗕𝗿𝗼𝘄𝘀𝗲𝗿™

Mindsigns Health™ is delighted to announce that we have been granted a patent with serial number 2020219705, for “Method and system for seizure detection” by the Australian Patent Office! The grant is effective as of July 3rd 2025.

This patent for the 𝙉𝙚𝙪𝙧𝙤𝗕𝗿𝗼𝘄𝘀𝗲𝗿™, our AI-powered automated EEG interpretation and analysis software, is in addition to our patent granted in Singapore in 2022. This further strengthens our global portfolio and will help drive our international expansion.

Michel Birnbaum, Co-Founder and CEO, commented: "This is another significant step for the Mindsigns Health™ platform and its 𝘕𝘦𝘶𝘳𝘰Browser™ product in our overall mission to develop clinically validated, secure, and affordable digital health products to improve brain health worldwide and provide a more efficient access to care."

Mindsigns Health™ develops AI powered tools to detect and track neuropsychiatric disorders more efficiently for improved access and outcomes.